Controlled Trial of Phetharbital, a Non-hypnotic Barbiturate, in Unconjugated Hyperbilirubinaemia
Open Access
- 29 May 1971
- Vol. 2 (5760), 497-499
- https://doi.org/10.1136/bmj.2.5760.497
Abstract
Eleven patients with mild unconjugated hyperbilirubinaemia (Gilbert's syndrome) took part in a double-blind cross-over trial of phenobarbitone and phetharbital, a non-hypnotic barbiturate. Significant reductions in plasma bilirubin were observed with both drugs, but six patients complained of sleepiness on phenobarbitone, and phetharbital was preferred by most patients. Phetharbital was also effective in the rare severe unconjugated hyperbilirubinaemia of the Crigler-Najjar syndrome (Type 2). Symptoms attributed to Gilbert's syndrome, including nausea and abdominal pain, were less consistently relieved.Keywords
This publication has 12 references indexed in Scilit:
- Constitutional hepatic dysfunction (Gilbert's syndrome): A new definition based on kinetic studies with unconjugated radiobilirubinAmerican Journal Of Medicine, 1970
- Mechanism of phenobarbital-induced hypercholeresis in the ratAmerican Journal of Physiology-Legacy Content, 1970
- TREATMENT OF GILBERT'S SYNDROME WITH PHENOBARBITONEThe Lancet, 1970
- Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiencyAmerican Journal Of Medicine, 1969
- Hepatic Bilirubin UDP-Glucuronyl Transferase Activity in Liver Disease and Gilbert's SyndromeNew England Journal of Medicine, 1969
- CONTROLLED TRIALS OF PHENOBARBITONE THERAPY IN NEONATAL JAUNDICEThe Lancet, 1969
- The Determination of Liver Mass from Radionuclide ImagesRadiology, 1968
- Stimulatory effect of N-phenylbarbital (phetharbital) on cortisol hydroxylation in manBiochemical Pharmacology, 1968
- STUDIES ON MECHANISM OF PHENOBARBITAL-ENHANCED SULFOBROMOPHTHALEIN DISAPPEARANCE1968
- Constitutional hepatic dysfunction (Gilbert's disease): its natural history and related syndromes.1959